Table 3.
Summary of Anterior Chamber Cells in Operative Eyes of Ebola Survivors and Controls Following Manual Small Incision Cataract Surgery
| Anterior Chamber Cells ≥ Grade 1 (6–15 Cells/HPF), n (%) | ||||
|---|---|---|---|---|
| Month | Ebola Survivors (n = 22 Eyes) | Controls (n = 12 Eyes) | Overall (N = 34 Eyes) | P a |
| 1 | 12 (54.5) | 8 (66.7) | 20 (58.8) | |
| 3 | 11 (50) | 2 (16.7) | 13 (38.2) | |
| 6 | 3 (14.3) | 3 (30) | 6 (19.4) | 0.593 |
| 9 | 3 (15.8) | 4 (33.3) | 7 (22.6) | |
| 12 | 0 (0) | 0 (0) | 0 (0) | |
A majority of eyes demonstrated persistent inflammation at 1 month, which decreased in frequency over 1 year.
a
Ebola survivors versus controls.